Welcome to the BSG Global Grand Rounds, brought to you by the International Section of the BSG. This webinar series aims to cover the SCE curriculum with speakers from across the globe giving us an international perspective on common gastro- intestinal conditions.

Learning points

• Look for iatrogenic causes (Metformin)
• Future role for non-invasive diagnostic markers
• Bile Acid Malabsorption may co-exist with other GI conditions

Meet our speakers

Prof Michael Camilleri, Mayo Clinic, Rochester

Michael Camilleri, M.D., D.Sc., is Professor of Medicine, Pharmacology, and Physiology at Mayo Clinic College of Medicine and Science, and Consultant in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, Minnesota. His research interests include clinical enteric neurosciences, gut neurohormonal control, obesity, irritable bowel syndrome, and pharmacology/pharmacogenomics.

He has received numerous awards and honours including the Ismar Boas Medal from the German Society of Digestive and Metabolic Disease, the Joseph B. Kirsner Award from the American Gastroenterological Association (AGA), and the AGA Julius Friedenwald Medal. He has mentored more than 80 national/international postdoctoral fellows/scientists. He is Past-President of the American Neurogastroenterology and Motility Society and the American Gastroenterological Association, and he is a current associate editor of Gut.

Prof Jervoise Andreyev, Lincoln County Hospital

Jervoise Andreyev had a Russian father and English mother. His first degree was in Arabic Studies. He qualified in Medicine in 1987 and completed a PhD in molecular biology in 1997. In 2000, he was appointed Senior Lecturer at Imperial College, London and in 2006, at the Royal Marsden Hospital, London became the first ever gastroenterologist worldwide specifically appointed to treat the GI side effects of biological, chemotherapy, radiotherapy and surgical treatments for cancer.

In 2016, he was the Nimmo Visiting Professor at the Royal Adelaide Hospital, Australia. In 2017, he moved from London to Lincoln County Hospital. In 2019, he was appointed Honorary Professor, the School of Medicine, the University of Nottingham. While working as a full time NHS clinician, he has raised approximately £5 million for research studies, published 150 papers, enrolled 1,500 patients into randomized trials and several thousand patients into interventional cohort studies.

His research has focused primarily on the GI toxicity of cancer treatments and he is acknowledged as a leader in this field. However, the findings from his research in patients with GI side effects of cancer therapies is increasingly being shown to have relevance for a wide range of GI disorders unrelated to cancer treatment

Prof Ramesh Arasaradnam, University Hospitals Coventry & Warwickshire

Ramesh is a Gastroenterologist and Professor of Medicine at University of Warwick and Leicester. He is currently the Academic Vice President of the Royal College of Physicians London. His research interest is varied from mechanistic insights into colon cancer, bile acid physiology but largely focused on diagnostic tools in cancer and inflammation to improve clinical pathways. He set up the first patient charity for bile acid diarrhoea – BAD, UK.